{"id":"W2418450403","doi":"10.1038/bjc.2016.119","title":"Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"Direction Générale de l’offre de Soins","keywords":"Medicine; Sorafenib; Toxicity; Quality of life (healthcare); Internal medicine; Adverse effect; Clinical endpoint; Melanoma; Phases of clinical research; Surgery; Progression-free survival; Oncology; Clinical trial; Chemotherapy; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005458883,0.00161056,0.002487446,0.000327629,0.0005161894,0.0008832487,0.0007458421,0.001117952,0.002185365],"category_scores_gemma":[0.002081887,0.0005701393,0.001763875,0.0005003349,0.000877692,0.0005054802,0.0004274118,0.001690057,0.0005758596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008491785,"about_ca_system_score_gemma":0.001937111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007022848,"about_ca_topic_score_gemma":0.001234043,"domain_scores_codex":[0.9983898,0.001036478,0.00008666502,0.0001357157,0.0001888938,0.0001624515],"domain_scores_gemma":[0.9979364,0.0002926838,0.0005264379,0.0001765954,0.0001419731,0.0009260431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7502991,0.07810902,0.03645281,0.002058857,0.003350128,0.001162903,0.0005902667,0.002690194,0.06127365,0.000167936,0.002946769,0.06089831],"study_design_scores_gemma":[0.4711739,0.4376082,0.08306572,0.00007426685,0.00102153,0.001193433,0.00008198293,0.001239439,0.002402292,0.0001264046,0.001958044,0.0000547845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958012,0.001846907,0.0004156256,0.0001896438,0.00003400388,0.001043477,0.0003437822,0.00002631428,0.0002991239],"genre_scores_gemma":[0.991915,0.001432265,0.001296769,0.0004582278,0.0001819207,0.002271591,0.001583041,0.00001825214,0.0008429704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005458883,"threshold_uncertainty_score":0.02886963,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05332202115739489,"score_gpt":0.400707147021521,"score_spread":0.3473851258641261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}